immunogenic

Related by string. Immunogenic * * highly immunogenic . immunogenic proteins . poorly immunogenic *

Related by context. All words. (Click for frequent words.) 71 highly immunogenic 65 orally bioavailable 64 immunogenicity 63 antibody responses 63 peptide antigens 63 M2e 63 immune responses 63 VZV 62 IFN alpha 62 attenuated strain 61 neutralizing antibody 61 live attenuated vaccines 61 Multimeric 61 immunologically 61 antigen 61 GM CSF 61 live attenuated influenza 60 antitumor activity 60 neutralizing antibodies 60 peripheral blood mononuclear 60 systemically administered 60 antiviral activity 60 synthetic peptide 60 antitumor 60 cytotoxicity 60 fusion protein 60 administered subcutaneously 59 antibody 59 Valortim R 59 VLPs 59 antigens 59 antibody titers 59 XmAb# 59 IFN gamma 59 AAV2 59 favorable pharmacokinetic profile 59 viral vector 59 plasmid DNA 59 potent inhibitor 59 decitabine 59 pharmacokinetic profile 58 potent antiviral 58 pharmacokinetic properties 58 tolerability profile 58 humanized antibody 58 GeoVax vaccines 58 Vacc 4x 58 ENMD # 58 MVA BN R 58 vaccine TIV 58 MUC1 58 pegylated 58 CHO cells 58 EpCAM 58 tumor antigen 58 Gleevec resistant 58 transgene expression 58 VLP vaccine 58 Sym# 58 IgG1 58 orally dosed 57 tumor specific antigen 57 thymalfasin 57 CYC# 57 intradermal injection 57 Pharmacokinetics PK 57 cidofovir 57 clade B 57 trivalent influenza vaccine 57 immune stimulatory 57 antibodies 57 pharmacodynamic properties 57 replicon 57 potent inhibitors 57 intratumoral injection 57 vaccinia virus 57 vWF 57 Human cl 57 nanoviricide 57 targeting CD# 57 PRTX 57 immunomodulator 57 Zysolin TM 57 interferon alfa 2b 57 interferon alpha 57 hTERT 57 PRT# 57 phosphorylate 57 DepoVax ™ 57 HCV protease 57 solithromycin 57 GHRH 57 RiVax 57 immunomodulators 57 virus AAV 56 binds selectively 56 effector function 56 L asparaginase 56 simian immunodeficiency virus 56 murine 56 adenoviral 56 oral prodrug 56 immunostimulatory 56 Ad5 56 glycosylated 56 TH# cells 56 BioVant 56 vaccine RiVax TM 56 IgG antibodies 56 dnaJP1 56 JVRS 56 oral bioavailability 56 anti leukemic 56 anti EGFR antibody 56 interferon IFN 56 serum antibody 56 DermaVir 56 nanomolar 56 sodium glucose cotransporter 56 surface glycoprotein 56 HGS ETR1 56 transfected cells 56 IFNa 56 cytotoxic 56 pDCs 56 CD8 responses 56 MVA BN 56 IgG antibody 56 IMA# 56 imatinib Gleevec ® 56 PDGF B 56 interferon beta 56 RDEA# 56 systemic absorption 56 bispecific 56 HER2/neu 56 Preclinical studies 56 polysaccharide vaccine 56 mcg dose 56 humanized anti 56 EphA2 56 rFIXFc 56 cultured cells 56 administered intramuscularly 56 EGFr 56 biodistribution 56 4CMenB 56 DepoVax 56 teriflunomide 56 μg ml 56 immunosuppressive 56 liposomal formulation 56 immunotoxin 56 Ankara MVA 56 HCV replicon 55 deacetylation 55 alkylating agent 55 annexin V 55 CTAP# Capsules 55 durable remissions 55 bevirimat 55 cytomegalovirus 55 nucleoside 55 TLR9 agonist 55 Azedra 55 #I TM# 55 Traficet EN 55 ceftriaxone 55 radiolabeled 55 vaccinia 55 busulfan 55 Radilex 55 HuMax CD4 55 administered orally 55 inecalcitol 55 HspE7 55 HuMax CD# 55 aT cell 55 protein antigens 55 pharmacodynamic PD 55 VSV G 55 TRIOLEX 55 immunized mice 55 monomeric 55 granulocyte colony stimulating 55 isotype 55 pharmacodynamic profile 55 transfection 55 cytolytic 55 transfected 55 TNF α 55 Tarvacin 55 Belerofon 55 DHFR 55 depsipeptide 55 biologically active 55 tumorigenic 55 milatuzumab 55 selective inhibitor 55 viral antigen 55 ara C 55 selective inhibition 55 NEUGENE antisense 55 immune modulatory 55 MF# adjuvanted 55 immunological 55 rHuPH# 55 pyruvate kinase 55 TriRima 55 Vidofludimus 55 mAbs 55 conjugate vaccine 55 adjuvant 55 Omacetaxine mepesuccinate 55 HBV vaccine 55 polymerase inhibitor 55 AAV vector 55 viral vectors 55 constitutively activated 55 active moiety 55 PEGylated Fab fragment 55 AAV vectors 55 butyrylcholinesterase 55 IFN ß 55 induces antibodies 55 antitumor effect 55 plasmid encoding 55 INT# [002] 55 CD4 + CD# 55 Bezielle 55 CR# vcMMAE 55 H#N# VLP vaccine 55 TLR8 55 pertussis toxin 55 immunoglobulin G 55 IL# [001] 55 induce apoptosis 55 antigen sparing 55 intranasal vaccine 55 FluCide 54 pharmacokinetic interactions 54 enveloped viruses 54 von Willebrand factor 54 MGd 54 prodrug 54 immunogen 54 purified protein 54 granisetron 54 tumorigenicity 54 Bortezomib 54 lipid particles 54 outer membrane proteins 54 Ad5 vector 54 tiotropium bromide 54 interferon γ 54 humoral antibody 54 Liposomal 54 quadrivalent vaccine 54 anticancer activity 54 panobinostat 54 nucleoside analogs 54 sunitinib Sutent ® 54 potent cytotoxic 54 seroprotection 54 induces apoptosis 54 FVIII 54 chemotherapeutics 54 Sphingomab 54 TB4 54 IgG 54 interferon 54 lopinavir 54 antiviral efficacy 54 receptor inhibitor 54 HGS ETR2 54 CCX# 54 Tamibarotene 54 Xanafide 54 USP# 54 anti CD# antibody 54 interleukin IL -# 54 subunit vaccine 54 reactogenicity 54 AMN# [001] 54 defensins 54 #beta estradiol 54 erlotinib Tarceva ® 54 INGN 54 adjuvanted 54 immune modulators 54 Interferon alpha 54 subcutaneously injected 54 lentiviral vectors 54 DAVANAT 54 Vaxfectin 54 Blinatumomab 54 IgA 54 immunotherapeutic 54 vitro studies 54 immune modulator 54 preclinically 54 HQK 54 CD# antibody [001] 54 CXB# 54 alfa interferon 54 antigenic 54 immunomodulatory 54 pegylated alpha interferon 54 antibody fragment 54 mGluR5 NAM 54 NEUGENE 54 ganciclovir 54 azacitidine 54 CERVARIX 54 VA# [002] 54 factor G CSF 54 PCK# 54 posaconazole 54 defensin 54 NOD SCID mice 54 calcitonin 54 Cyclin E 54 indibulin 54 cytotoxin 54 VEGF receptor 54 SCIg 54 virulence genes 54 nanoviricides 54 conserved antigens NP 54 Protexia R 54 LT NS# 54 EGF receptor 54 neurotoxicity 54 TG# [001] 54 LY# [003] 54 tetravalent 54 DFMO 54 VAX# 54 PROCHYMAL 54 PEGylated 54 proteinase 54 ISF# 54 Immunohistochemical analysis 54 cytoprotective 54 favorable pharmacokinetic 54 PlGF 54 systemic toxicity 54 HBV replication 54 ganetespib 54 immunomodulating 54 chimeric monoclonal antibody 54 activin 54 hGH CTP 54 mesothelin 54 interferon lambda 54 LC#m# 54 Antigenics QS 54 retapamulin 54 alpha2 54 peptide 54 QbG# 54 TLR9 54 interferon alfa 54 Voreloxin 54 HER2 receptor 54 EGFRvIII 54 synthetic peptides 54 monoclonal 54 CD# [002] 54 camptothecin 54 RNAi compounds 54 CD# antigen 54 nucleoside analogues 54 novel peptide 54 intramuscular 54 NFkB 54 IFNg 54 MF# adjuvanted vaccine 54 Imprime PGG 54 dose limiting toxicities 54 IgG1 antibody 53 tolerability 53 bleomycin 53 acid phosphatase PAP 53 titers 53 myeloma cells 53 seliciclib 53 epitope 53 nanomolar range 53 gp# [002] 53 Factor IX 53 Valortim 53 oncoproteins 53 Hsp# inhibitors 53 UsiRNAs 53 hematopoietic cells 53 #ME# 53 OncoVEX GM CSF 53 TTR gene 53 neutralizing antibody responses 53 androgen receptor AR 53 mg kg dose 53 phosphatidylserine 53 MVA BN ® 53 calcitriol 53 HCV NS3 protease 53 nucleosides 53 PTP 1B 53 physiologically relevant 53 soluble tumor necrosis 53 cytotoxic T 53 Seliciclib 53 tumor lysate 53 estrogen receptor beta 53 c myc 53 metastatic RCC 53 Dasatinib 53 ESBA# 53 tumor antigens 53 GelVac TM 53 recombinant protein 53 heterologous 53 IgA antibodies 53 PTHrP 53 recombinant 53 monoclonal antibody 53 prostate epithelial cells 53 bortezomib 53 ZFN modified 53 intravenously administered 53 phosphorylated 53 LRP6 53 antitumor efficacy 53 SynCon ™ DNA 53 IL 1beta 53 SGLT2 53 GLYX 53 TRAIL R2 53 recombinant enzyme 53 viral antigens 53 HCV replication 53 CpG 53 Valortim ® 53 cytokines IL 53 PDGFR 53 mAb 53 polyclonal 53 prodrugs 53 PLX cells 53 titer 53 JAK inhibitors 53 recombinant adeno associated 53 ansamycin 53 amphotericin B 53 53 muscarinic 53 IgM antibodies 53 mertansine 53 Menveo 53 multivalent vaccine 53 CBLC# 53 HLA B# 53 DepoVax TM 53 mature dendritic cells 53 WT1 53 NEUMUNE 53 immunologic 53 lentiviral vector 53 CD#c 53 Thiovir 53 PI3K inhibitor 53 TNFa 53 IFN beta 53 HCV genotypes 53 Pegasys ® 53 binding affinity 53 Eg5 53 GRNVAC1 53 selective modulator 53 PBMCs 53 OMP #M# 53 MAb 53 dasatinib Sprycel ® 53 polyclonal antibody 53 heavily pretreated 53 antisense drug 53 chemotherapeutic agent 53 PREVENAR 53 thymosin 53 osteoinductive 53 Th2 cytokines 53 potent anticancer 53 SIV infection 53 VEGFb 53 oncogenic 53 alkylating agents 53 antifibrotic 53 inhibit replication 53 Th# cells 53 CCR9 53 rPA 53 equimolar 53 Engerix B 53 amino acid sequence 53 immunotoxins 53 downregulated 53 RNA sequences 53 preclinical studies 53 PEGylated anti 53 antigenicity 53 efficacious 53 HepaGam B 53 rBChE 53 Darinaparsin 53 ovalbumin 53 chemotherapeutic agents 53 nephrotoxicity 53 HEK# cells 53 Etoposide 53 administered intranasally 53 cytotoxic agents 53 IL #p# 53 influenza VLP vaccine 53 immunoglobulin Ig 53 ISTODAX 53 HIF 1a 53 intranasal formulation 53 BALB c mice 53 CCL# 53 iNOS 53 HDACi 53 immunogens 53 bile acid 53 B7 H3 53 TRAIL receptor 53 forskolin 53 antiviral potency 53 daunorubicin 53 CYT# 53 interferon therapy 53 irreversible inhibitor 53 polymerase inhibitors 53 humoral responses 53 selective agonist 53 thioredoxin 53 anthrax toxin 53 CMV infection 53 co stimulatory molecules 53 parainfluenza virus 52 GRN#L 52 ErbB3 52 serotype 52 monovalent 52 CIMZIA TM 52 poorly immunogenic 52 aluminum hydroxide adjuvant 52 bispecific antibody 52 ROTARIX 52 GPx 52 dsRNA 52 Tyrima 52 siRNA 52 C1 INH 52 xenograft models 52 peptides 52 CD8 T cell 52 pan HDAC inhibitor 52 capsular polysaccharide 52 somatostatin 52 dendritic cell 52 adefovir 52 immunodominant 52 pomalidomide 52 chemically modified siRNA 52 cytochrome P# #A# 52 act synergistically 52 XL# inhibits 52 CCR2 52 trivalent vaccine 52 anti CD3 52 Clusterin 52 4E BP1 52 gemcitabine cisplatin 52 GV# [001] 52 seroconversion 52 interferon gamma 52 inhibitory activity 52 huC# DM4 52 methylated DNA 52 protective antigen 52 antiangiogenic 52 COPEGUS 52 varicella zoster virus VZV 52 HbF 52 monoclonal antibody mAb 52 TriGrid ™ 52 Linaclotide 52 immunocompetent 52 ZOSTAVAX 52 adenovirus vector 52 Cyclosporine 52 REP# 52 humanized monoclonal antibody 52 liposomal 52 BAL# [001] 52 doxorubicin 52 cytokine interleukin 52 immune modulating 52 MenACWY CRM 52 MEK inhibitors 52 PI3K Akt 52 metaglidasen 52 trabectedin 52 varicella zoster virus 52 cellular uptake 52 geldanamycin 52 poxvirus 52 LEAPS vaccines 52 Aptivus ® 52 nanoparticle formulation 52 humoral immunity 52 Carfilzomib 52 nelfinavir 52 CD# molecule 52 IMPDH 52 transcriptase inhibitor NNRTI 52 elacytarabine 52 HPV# 52 ActA 52 serine protease 52 IMC A# 52 octreotide 52 H#N# antigen 52 DiLA2 52 viral proteins 52 nucleoside analog 52 SAR# [004] 52 ADAM# 52 Excellarate 52 NS4A 52 pluripotent cells 52 INVANZ 52 Navelbine ® 52 humanized monoclonal 52 NXL# 52 Peginterferon 52 IGFBP 3 52 plasma kallikrein inhibitor 52 GRP# 52 IgG4 52 proteasome inhibitor 52 extracellular domain 52 proteolytic cleavage 52 Fc fusion protein 52 Elacytarabine 52 Peg IFN 52 otelixizumab 52 elastase 52 IL #E 52 Virulizin ® 52 Aclidinium 52 investigational monoclonal antibody 52 siRNAs 52 constitutively 52 vorinostat 52 siRNA mediated 52 syngeneic 52 glycosylation profile 52 PEG Interferon lambda 52 oritavancin 52 IFN γ 52 Annexin V 52 pDNA 52 vidofludimus 52 hepatoma 52 small molecule inhibitors 52 lytic 52 TAp# 52 glucocorticoid 52 inactivated influenza virus 52 Inactivated 52 murine leukemia virus 52 ImmunoVEX HSV2 52 IDX# 52 NRTIs 52 Th1 type 52 aminopeptidase 52 adenovirus serotype 5 52 synthetic analogues 52 vaccine serotypes 52 trivalent 52 NS#/#A protease 52 DAS# [001] 52 siRNA molecule 52 E. faecalis 52 tigecycline 52 azelaic acid 52 keratinocyte 52 inactivated vaccine 52 ACAM FLU 52 CDDO Im 52 VP# [004] 52 IL 1ß 52 Altastaph 52 Cyclosert 52 mycobacterial 52 xenografts 52 neuroprotective properties 52 Immune responses 52 triphosphate 52 apoptotic pathway 52 subcutaneously administered 52 refractory acute myeloid 52 PXD# 52 AEG# 52 stable nucleic acid 52 inflammatory cytokine 52 immunological responses 52 MET amplification 52 dimerization 52 homodimers 52 5 HT4 receptor 52 MDSCs 52 LHRH agonists 52 tolerogenic 52 humanized antibodies 52 protease inhibitor 52 BMS# 52 convenient dosing regimens 52 pharmacologically active isomer 52 PENNVAX B 52 radezolid 52 Symadex 52 angiogenesis inhibitor 52 demonstrated antitumor activity 52 idarubicin 52 vinca alkaloid 52 proto oncogene 52 PrP 52 flavopiridol 52 naturally occurring molecule 52 Alphanate R 52 protein encoded 52 Zalypsis 52 amplicons 52 AVI NEUGENE 52 parthenolide 52 oncolytic viruses 52 Vorinostat 52 mitoxantrone 52 viral genomes 52 chemotherapeutic drug 52 quinolone 52 hippocampal neurons 52 trivalent inactivated influenza 52 Luteinizing Hormone Releasing Hormone 52 azacytidine 52 leucovorin 52 glioma cells 52 HCD# [002] 52 hA# 52 Pralatrexate 52 selectively binds 52 HER-2/neu 52 vimentin 52 cilengitide 52 meropenem 52 Homspera 51 IgM 51 pegfilgrastim 51 inactivated influenza vaccine 51 Fc receptor 51 ErbB 51 pro angiogenic 51 acellular pertussis vaccine 51 dosing frequency 51 intradermally 51 HuMax EGFr 51 LB# [003] 51 anticancer agent 51 Epstein Barr virus EBV 51 novel VDA molecule 51 CCR9 antagonist 51 humanized monoclonal antibodies 51 botulinum neurotoxin 51 caspofungin 51 S1P 51 nasal powder 51 FLT3 51 IMGN# 51 anti angiogenic 51 non nucleoside 51 intravesical 51 tubulin polymerization 51 potent antiproliferative 51 delta isoform 51 adalimumab Humira 51 anticancer therapies 51 mitochondrial fusion 51 NNRTIs 51 Sanofi Pasteur Fluzone 51 ORMD 51 alefacept 51 clinical trials Multikine 51 adjuvanted vaccine 51 toxoids 51 Sudhir Agrawal D.Phil 51 pRb 51 Alocrest 51 preclinical models 51 CDK inhibitor 51 hematological cancers 51 short hairpin RNAs 51 YONDELIS 51 HepG2 cells 51 taxanes 51 MDR1 51 GPNMB 51 bone marrow stromal cells 51 cisplatin chemotherapy 51 LRP5 51 delafloxacin 51 VEGF receptors 51 attenuated vaccine 51 Factor VIIa 51 enzyme inhibitor 51 granulocyte macrophage colony stimulating 51 FGFR 51 chemically synthesized 51 antisense oligonucleotides 51 partial agonist 51 radiolabeled monoclonal antibody 51 epitopes 51 ALV# 51 pneumococcal serotypes 51 abacavir lamivudine 51 trophoblast cells 51 viral kinetics 51 siRNA molecules 51 plasmin 51 Interferon gamma 51 bactericidal activity 51 lymphocyte counts 51 polypeptides 51 pDNA vaccines 51 effector memory 51 HuLuc# 51 E1A 51 HBsAg 51 K ras mutations 51 TGF ß 51 nucleoside analogue 51 PSMA ADC 51 Th1 51 anti angiogenic drugs 51 canakinumab 51 selective adenosine 51 isomerase 51 STAT3 signaling 51 anti proliferative 51 Th2 51 prophylactically 51 phosphatases 51 vinorelbine 51 uricase 51 Trastuzumab 51 mimetics 51 valine 51 sCD# 51 IRX 2 51 palivizumab 51 FGFR2 51 radiation sensitizer 51 Hizentra 51 transduced 51 IFNs 51 iRGD 51 OHR/AVR# 51 oncolytic virus 51 fusion proteins 51 Adalimumab 51 MTHFR 51 Anthim 51 lentiviral 51 LY# [002] 51 CD# antibodies 51 invasive candidiasis 51 mitomycin 51 p# activation 51 purified recombinant 51 ritonavir boosted protease inhibitor 51 cetuximab Erbitux R 51 adenovirus vectors 51 idiotype 51 proteasome inhibitors 51 splice variants 51 Ribavirin 51 chemokine receptor 51 LEX System 51 reproducibly 51 avidin 51 chimeric protein 51 retinoic acid receptor 51 lead Aganocide compound 51 humoral immune responses 51 supernatants 51 ritonavir boosted 51 MVA#A 51 CCR5 tropic 51 CXCL# 51 Combination therapy 51 BChE 51 pharmacologically active 51 anti amnesic 51 B lymphocyte stimulator 51 IL #R 51 NGX# 51 Mesothelin 51 piroxicam 51 Plicera 51 immunostimulant 51 raltegravir 51 Nanobody 51 serotypes 51 protease inhibitor PI 51 glioblastoma cells 51 Twinrix 51 immune suppressive 51 preclinical studies Tekmira SNALP 51 AhR 51 INCB# [001] 51 immunomodulatory therapy 51 hepatocytes 51 adeno associated viruses 51 MIF protein 51 ceftazidime 51 TLR agonists 51 forodesine 51 plasmid DNA vaccine 51 IL 1β 51 IGF 1R 51 JAK2 51 antisense compounds 51 recombinant vaccine 51 THR beta agonist 51 Tolerability 51 IgGs 51 VAPRISOL 51 CAIV T 51 T#I mutant 51 ALB # 51 ketorolac 51 pyrimidine 51 DiLA2 liposomes 51 nanoviricide drug 51 luteinizing hormone releasing 51 adeno associated virus 51 clusterin 51 idraparinux 51 proteoglycan 51 downregulation 51 somatostatin analogue 51 Anticalins ® 51 CANCIDAS 51 potent anti angiogenic 51 CD# + [001] 51 external genital lesions 51 oral rivaroxaban 51 HCV protease inhibitors 51 antisense oligonucleotide 51 HDAC 51 CEQ# 51 EGFR antibodies 51 cellular cytotoxicity 51 Maribavir 51 protein secretion 51 alpha interferon 51 K#R [002] 51 mediated immunity 51 pharmacokinetic 51 UsiRNA 51 intravenous bisphosphonates 51 tolerability profiles 51 GeoVax vaccine 51 sulindac 51 Orally administered 51 mucosal immunity 51 constitutively expressed 51 lymphoid organs 51 PB1 F2 51 dihydrofolate reductase 51 anti HBs 51 rifamycins 51 5alpha reductase 51 CMV reactivation 51 heterodimers 51 V#F mutation 51 pegylated interferon alpha 51 Tarvacin TM

Back to home page